E. Fox

Incidence of neutropenic fever in patients treated with standard-dose combination chemotherapy for small-cell lung cancer and the cost impact of treatment with granulocyte colony-stimulating factor.

L. Einhorn, B. Roth, P. Loehrer, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Weekly paclitaxel and gemcitabine in advanced transitional-cell carcinoma of the urothelium: a phase II Hoosier Oncology Group study.

C. Yiannoutsos, L. Einhorn, C. Sweeney, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Outcome analysis for patients with persistent nonteratomatous germ cell tumor in postchemotherapy retroperitoneal lymph node dissections.

T. Ulbright, L. Einhorn, J. Donohue, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Extragonadal and pediatric germ cell tumors.

Craig R. Nichols, E. Fox, 1991, Hematology/oncology clinics of North America.

Persistent cancer in postchemotherapy retroperitoneal lymph-node dissection: outcome analysis

T. Ulbright, L. Einhorn, P. Loehrer, 1994, World Journal of Urology.

T-cell lymphoma, tropical spastic paraparesis, and malignant fibrous histiocytoma in a patient with human T-cell lymphotropic virus, type 1.

W. Blattner, E. Defreitas, C. Gibbs, 1989, Annals of internal medicine.

Chemotherapy for advanced testicular cancer.

L. Einhorn, P. Loehrer, S. Williams, 1984, Hematology/oncology clinics of North America.

Treatment of carcinoma of unknown primary site (CUP) directed by molecular profiling diagnosis: A prospective, phase II trial.

M. Erlander, J. Hainsworth, C. Schnabel, 2010 .

Cisplatin, fluorouracil, celecoxib, and RT in resectable esophageal cancer: preliminary results.

N. Fineberg, N. Hanna, R. Govindan, 2004, Oncology.

Outcome Analysis for Patients with Persistent Non-Seminomatous Germ Cell Tumour in Post-Chemotherapy Retroperitoneal Lymph Node Dissections

T. Ulbright, L. Einhorn, P. Loehrer, 1994 .